Starting Sunday, October 29, industry leaders in transcatheter cardiovascular innovation will convene in Denver, Colorado for TCT 2017. Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center for transcatheter innovation and education. The goal? As always, to improve patient care.
GCMI and its subsidiary T3 Labs will be exhibiting again this year at booth 6001 and sharing their latest developments and experiences with emerging cardiovascular therapies at TCT 2017.
In addition to catching up with past and current T3 Labs sponsors, the conference serves as an opportunity to connect with government and CDRH officials. We look forward to meeting with these device and regulatory experts to further understand what they look for in transcatheter innovations and how we can better design preclinical studies for cardiothoracic devices.
Designed by cardiologists for cardiologists and other medical device developers
T3 Labs is an industry leading preclinical CRO for cardiothoracic device testing and training with one goal in mind: taking new ideas for better medical devices, biologics, and drugs and making them into functional products.
From transcatheter valve replacements and repairs, peripheral interventional therapies, catheter based heart assist devices, arrhythmia therapies and more, T3 Labs stands ready to support cardiovascular innovation by helping innovators maximize their investment in preclinical testing and bioskills training needs.
Related: Surefire Precision gains FDA 510(k) clearance twice as fast as the industry average with T3 Labs
T3 Labs sets gold standard in preclinical testing for CorAmi: a medtech company revolutionizing drug delivery for Atrial Fibrillation
Selecting a New Preclinical Trials Partner – T3 Labs & ALung’s Hemolung RAS in a Calf Model
Connect with our industry leading preclinical CRO scientists at TCT 2017!
If you are a physician innovator with a ‘back of the napkin’ idea for a new cardiothoracic device, a medical device company of any shape or size evaluating a new cardio product’s readiness for preclinical, or if you just want to talk about the latest in transcatheter cardiovascular therapeutics, stop by booth #6001 to connect with us, contact Deepal Panchal or contact us here to schedule an onsite meeting.